- Home
- IMMP vs MQT Comparison
IMMP vs MQT Comparison
Compare IMMP & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- MQT
- Stock Information
- Founded
- IMMP 1987
- MQT 1992
- Country
- IMMP Australia
- MQT United States
- Employees
- IMMP N/A
- MQT N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- MQT Investment Bankers/Brokers/Service
- Sector
- IMMP Health Care
- MQT Finance
- Exchange
- IMMP Nasdaq
- MQT Nasdaq
- Market Cap
- IMMP 244.5M
- MQT 207.5M
- IPO Year
- IMMP N/A
- MQT N/A
- Fundamental
- Price
- IMMP $1.80
- MQT $9.41
- Analyst Decision
- IMMP Buy
- MQT
- Analyst Count
- IMMP 1
- MQT 0
- Target Price
- IMMP $7.00
- MQT N/A
- AVG Volume (30 Days)
- IMMP 69.1K
- MQT 52.5K
- Earning Date
- IMMP 02-27-2025
- MQT 01-01-0001
- Dividend Yield
- IMMP N/A
- MQT 4.60%
- EPS Growth
- IMMP N/A
- MQT N/A
- EPS
- IMMP N/A
- MQT N/A
- Revenue
- IMMP $3,019,249.00
- MQT N/A
- Revenue This Year
- IMMP $50.37
- MQT N/A
- Revenue Next Year
- IMMP N/A
- MQT N/A
- P/E Ratio
- IMMP N/A
- MQT N/A
- Revenue Growth
- IMMP 24.11
- MQT N/A
- 52 Week Low
- IMMP $1.32
- MQT $8.59
- 52 Week High
- IMMP $2.72
- MQT $10.67
- Technical
- Relative Strength Index (RSI)
- IMMP 59.33
- MQT 42.37
- Support Level
- IMMP $1.60
- MQT $9.33
- Resistance Level
- IMMP $1.83
- MQT $9.42
- Average True Range (ATR)
- IMMP 0.05
- MQT 0.09
- MACD
- IMMP 0.02
- MQT -0.00
- Stochastic Oscillator
- IMMP 84.78
- MQT 17.35
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, Housing, Corporate, and Tobacco.